UCLH-6630 - LECANEMAB HOMECARE SERVICE_英国招投标_中文版

• 首页 > 英国 > UCLH-6630 - LECANEMAB HOMECARE SERVICE

加载中...

UCLH-6630 - LECANEMAB HOMECARE SERVICE

发布时间	所属地区	所属机构	语言
2025年03月05日	--	--	英语 (English) 中文

Published date: 5 March 2025

Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.

Watch this notice Print this notice

Contract summary

Industry

Pharmacy services - 85149000

Location of contract

NW1 2PB

Value of contract

£81,600 to £816,000

Procurement reference

CF-2881000D0O000000rwimUAA

Published date

5 March 2025

Closing date

26 March 2025

Closing time

12pm

Contract start date

3 November 2025

Contract end date

2 November 2027

Contract type

Service contract

Procedure type

Open procedure (above threshold)

What is an open procedure (above threshold)?

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Contract is suitable for VCSEs?

Description

The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.

More information

Additional text: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk